Monday, January 18, 2021
wellness India Expo
Home Tags Cipla

Tag: Cipla

CSIR-CDRI & Cipla Foundation partner for a one-of-its-kind research & outreach...

Putting into action, the recent GOI’s provision for CSR funding to support research...................

Cipla launches ‘CIPtest’ rapid antigen detection test for COVID-19 diagnosis

Validated and approved by ICMR, the test is found to have specificity and sensitivity of 98.09% and up to 75% respectively. This is Cipla’s second launch in the diagnostics space after Elifast: SARS CoV-2 IgG ELISA Test Kit......................

Cipla launches ‘Covi-G’ for COVID-19 rapid antibody detection

Cipla signed a licensing agreement with MultiG for COVID-19 rapid antibody test kit..................

Cipla launches ‘ELIFast’ IgG ELISA test for COVID-19 antibody detection

As part of this collaborative effort, Cipla will be responsible for the marketing and distribution of the SARS CoV-2-IgG antibody detection ELISA that will be manufactured by KARWA...............

Stempeucel, first ‘Made in India’ cell therapy to treat Critical Limb...

Developed by Stempeutics over a period of twelve years, the breakthrough treatment designed to address the root cause of Critical Limb Ischemia at an affordable cost will be marketed and distributed in India by Cipla.....................

Cipla gets regulatory nod to launch Ciplenza for mild & moderate...

Cipla Limited has announced that it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.................

Cipla expands partnership with Roche Pharma to improve access to key...

Cipla signs a distribution agreement with Roche Products (India) Pvt. Ltd. to expand scope of the partnership to include, marketing and distribution of Roche’s trademark oncology drugs - Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab (Ristova) in India.........................

“We aim to bring newer drug innovations to the Indian market”

Mentioned Luca Visini, Managing Director, Eli Lilly & Company India in an exclusive interaction with BioVoice where he outlined the goals of his company driven by innovation including pursual of new drug development and working towards medicines reaching people at large through different channels.....................

CDRI Lucknow celebrates its 69th annual day, hosts talk by Cipla...

"We are at the threshold of an Indian scientific revolution. This requires us to rethink, redesign and rebuilt our scientific base through appropriate technology” said Dr Y K Hamied while delivering the 45th Sir Mellanby oration.......................

Cipla Foundation sets up a state-of-the-art chemistry laboratory at IISER Pune

The lab aims to provide practical training in Chemistry to undergraduates and researchers in the varsity campus along with support to the national outreach programme for school children..................